Aquilo Capital Management, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
Aquilo Capital Management, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$23,611,239
-9.1%
908,4740.0%22.76%
+16.9%
Q1 2024$25,982,356
-6.5%
908,4740.0%19.47%
+12.4%
Q4 2023$27,799,304
+13.9%
908,4740.0%17.32%
-21.7%
Q3 2023$24,410,696
-20.3%
908,474
+5.8%
22.12%
+30.4%
Q2 2023$30,613,183
+18.3%
858,474
-15.7%
16.96%
+58.2%
Q1 2023$25,869,240
-42.2%
1,018,474
-7.7%
10.72%
-36.2%
Q4 2022$44,758,568
+11.1%
1,103,515
-9.4%
16.81%
+15.8%
Q3 2022$40,272,000
-4.6%
1,218,515
+1.7%
14.52%
+0.8%
Q2 2022$42,200,000
-12.4%
1,198,515
+14.4%
14.40%
+103.4%
Q1 2022$48,172,000
+3.7%
1,047,440
+49.5%
7.08%
+34.4%
Q4 2021$46,438,000
+40.9%
700,426
+32.7%
5.27%
-12.0%
Q3 2021$32,958,000
-8.1%
527,926
+21.9%
5.99%
-35.7%
Q2 2021$35,855,000
+32.6%
432,926
+6.1%
9.32%
+90.6%
Q1 2021$27,050,000
-3.7%
407,926
+11.5%
4.89%
-16.2%
Q4 2020$28,078,000
+24.6%
365,926
-30.1%
5.84%
+144.6%
Q3 2020$22,538,000
-7.4%
523,415
-7.1%
2.39%
-51.4%
Q2 2020$24,329,000
+93.7%
563,291
+29.0%
4.91%
+0.2%
Q1 2020$12,559,000
-15.0%
436,514
-21.7%
4.90%
-4.5%
Q2 2019$14,773,000
-18.1%
557,455
-43.3%
5.13%
-35.7%
Q1 2019$18,028,000
+36.3%
982,455
-7.7%
7.98%
+24.7%
Q4 2018$13,226,0001,064,9286.40%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
ELEMENT CAPITAL MANAGEMENT LLC 142,649$618,0000.25%
ING GROEP NV 808,229$3,500,0000.07%
A.R.T. Advisors, LLC 232,470$1,006,0000.05%
OppenheimerFunds, Inc. 3,000,000$12,990,0000.02%
Edge Wealth Management LLC 10,000$43,0000.01%
First Allied Advisory Services, Inc. 61,000$264,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$866,0000.01%
MILLENNIUM MANAGEMENT LLC 1,272,138$5,508,0000.01%
D. E. Shaw & Co., Inc. 971,768$4,208,0000.01%
Virtu Financial LLC 18,008$78,0000.00%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders